insights_auto
Why is MESO down 3.95%?
Dive Deeperchevron_right
MESO:NASDAQ
Mesoblast Ltd
$11.18
arrow_downward
-3.95%(-0.46) 1D
$11.18
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 19, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
$11.51
High
$11.56
Low
$11.02
Mkt. cap
1.48B
Avg. vol.
269.12K
Volume
0.00
52-wk high
$21.49
52-wk low
$11.02
EPS
-$0.44
Beta
2.21
Shares outstanding
130.13M
No. of employees
108
Open
$11.51
High
$11.56
Low
$11.02
Mkt. cap
1.48B
Avg. vol.
269.12K
Volume
0.00
52-wk high
$21.49
52-wk low
$11.02
EPS
-$0.44
Beta
2.21
Shares outstanding
130.13M
No. of employees
108
News stories
From web sources and news partners
Investing.com UK
·
1 day ago
Mesoblast at Bell Potter Healthcare Conference: pipeline, sales and filings By Investing.com
Kalkine
·
1 day ago
Why is Ryoncil changing the revenue profile at Mesoblast (ASX:MSB)?
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd
CEOSilviu Itescu
Employees108
Founded2004
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitemesoblast.com